Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6AED
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,211
Award facts
- Contract value 100% obligated
- $23,211.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $23,211.00 on August 25, 2025, for XOLAIR 150 mg/ml syringes. The contract is firm fixed price with no set-aside designation and is scheduled for ultimate completion on September 16, 2025. The place of performance is Park Ridge, Illinois. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical supplies supporting military health facilities worldwide.
The funding agency is the Medical Supply Chain division of the Department of Defense, reflecting the contract's role in sustaining pharmaceutical supply chains for military healthcare operations. XOLAIR (omalizumab), a biologic medication used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria, represents the specialized pharmaceutical products that DMS Pharmaceutical Group routinely delivers to federal healthcare systems. As a long-standing federal contractor registered in the System for Award Management (SAM.gov) since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in distributing prescription medications, biologics, and medical consumables across the Department of Defense healthcare network.
Quick answers
Who was awarded contract SPE2DX25F6AED?
SPE2DX25F6AED was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6AED worth?
The government has obligated $23,211 on SPE2DX25F6AED.
Is contract SPE2DX25F6AED an order under another contract?
Yes. SPE2DX25F6AED is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AED competed?
The extent of competition for SPE2DX25F6AED was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award